Researchers from University of Lausanne Describe Findings in Vaccines

2011 SEP 28 -- New investigation results, "The Vaccine Formulation Laboratory: a platform for access to adjuvants," are detailed in a study published in Vaccine. According to the authors of recent research from Epalinges, Switzerland, "Adjuvants are increasingly used by the vaccine research and development community, particularly for their ability to enhance immune responses and for their dose-sparing properties. However, they are not readily available to the majority of public sector vaccine research groups, and even those with access to suitable adjuvants may still fail in the development of their vaccines because of lack of knowledge on how to correctly formulate the...

Want to see the full article?

• Purchase this article for only $3.00